Patents Assigned to Bayer
  • Patent number: 6780895
    Abstract: Improvements in tuft bind and/or elongation of tufted carpet may be achieved by selecting, as components of a tuft bind adhesive, one or more of: i) a polyol component comprising a low or ultra-low unsaturation polyoxypropylene polyol optionally containing up to 30 weight percent oxyethylene moieties, and ii) a chain extender component comprising 2-methyl-1,3-propanediol.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: August 24, 2004
    Assignee: Bayer Antwerp, N.V.
    Inventors: Ulrich B. Holechovsky, David Gibala, Jeffrey L. Robbins, Robert D. Duffy
  • Patent number: 6780859
    Abstract: This invention relates to novel benzofuran and dihydrobenzofuran compounds, pharmaceutical compositions containing such compounds, and methods of treating beta-3 adrenoreceptor-mediated conditions with such compositions.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 24, 2004
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Gaetan H. Ladouceur, William R. Schoen, Michael J. Burke
  • Publication number: 20040161854
    Abstract: The present invention relates to a novel device and method for the detection of lithium ions in a biological fluid. In a preferred embodiment, the present invention provides a novel compound and a optical sensor which incorporates said compound for the detection of lithium ions. Additionally, the present invention provides a method of detecting lithium ions which comprises placing the novel optical sensor into communication with a biological fluid. Once the novel compound of the present invention encounters a lithium ion(s), a fluorescence is generated, the intensity of which is measured and allows for the determination of lithium ion concentration. The present invention provides a medical professional with the ability to selectively determine lithium ion concentration in a biological fluid thereby facilitating the treatment of various diseases, such as manic-depressive illness.
    Type: Application
    Filed: February 11, 2004
    Publication date: August 19, 2004
    Applicants: Bayer HealthCare LLC, Worcester Polytechnic Institute
    Inventors: John S. Benco, Hubert A. Nienaber, W. Grant McGimpsey
  • Patent number: 6777556
    Abstract: The present invention relates to a process for preparing 2-haloalkylnicotinic acids and haloalkylnicotinic acid derivatives starting from halomethyl-substituted enones and 3-dialkylaminoacrylic esters and also to intermediates of the process according to the invention.
    Type: Grant
    Filed: February 24, 2003
    Date of Patent: August 17, 2004
    Assignee: Bayer Chemicals AG
    Inventor: Peter Müller
  • Patent number: 6779193
    Abstract: A digital data storage assembly (2), e.g., a flexible thin film compact disc, is described. Digital data storage assembly (2) includes, (a) a thin film data storage carrier (11), having substantially opposed first (14) and second (17) surfaces, an aperture (20), and at least one tab (23, 26) extending partially into aperture (20). The assembly (2) also includes, (b) a rigid support (29) having substantially opposed first (32) and second (35) surfaces, and an aperture (38). The assembly (2) further includes, (c) a locking device (41) positioned at least partially around aperture (38) of rigid support (29). Locking device (41) includes at least one shelf (44, 47) extending out over a portion of the first surface (32) of rigid support (29). The shelf (e.g., 44) and a portion (e.g., 53) of the first surface (32) of rigid support (29) residing thereunder together define a tapered slot (e.g., 62), having an open end (59) and a closed end (56).
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: August 17, 2004
    Assignee: Bayer Polymers LLC
    Inventors: Ronald A. Boissonneault, Ramesh M. Pisipati, Anthony L. Gelardi, Tatiana L. Gelardi
  • Patent number: 6777442
    Abstract: The present invention relates to compounds of the general formula (I) in which X represents O, S, SO, SO2, CH2, CHF, CF2 or NR8, and Z represents a group of the formula in which A represents O or S, the subscript “a” is 0 or 1, group D represents a straight-chain (C1-C4)-alkylene group, and R36 represents OR37 or NR38R39. It also relates to processes for preparation of such compounds and to their use in medicaments for the treatment of depression, goiter, cancer of the thyroid gland, arteriosclerosis, hypercholesterolaemia, dyslipidaemia, obesity, cardiac insufficiency, pulmonary emphysema, pain, migraine, Alzheimer's disease, osteoporosis, cardiac arrhythmias, hypothyroidism, skin disorders or diabetes.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: August 17, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Helmut Haning, Michael Woltering, Gunter Schmidt, Christiane Faeste, Hilmar Bischoff, Axel Kretschmer, Verena Vöhringer, Peter Ellinghaus
  • Patent number: 6776994
    Abstract: There are described new active compound combinations of a compound of the formula (I) with known fungicidal active compounds, and their use for the control of phytopathogenic fungi.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: August 17, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wilhelm Brandes, Heinz-Wilhelm Dehne, Stefan Dutzmann, Karl-Heinz Kuck, Bernd-Wieland Krüger
  • Patent number: 6777551
    Abstract: The present invention relates to a process for the preparation of sulphonamide-substituted imidazotriazinones of the general formula (I) characterized in that compounds of the formula (II) are reacted with sulphuric acid and the products obtained are then reacted with thionyl chloride and converted in situ in an inert solvent using an amine into the compounds according to the invention and, if appropriate, reacted to give the corresponding salts, hydrates or N-oxides.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: August 17, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Marc Nowakowski, Reinhold Gehring, Werner Heilmann, Karl-Heinz Wahl
  • Patent number: 6777416
    Abstract: The invention relates to novel isoxazolo pyrimidinones of general formula (I), a method for producing the same and the pharmaceutical use thereof.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: August 17, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ulrich Niewöhner, Helmut Haning, Thomas Lampe, Mazen Es-Sayed, Gunter Schmidt, Erwin Bischoff, Klaus Dembowsky, Elisabeth Perzborn, Karl-Heinz Schlemmer
  • Patent number: 6777523
    Abstract: The invention relates to polyether-modified, water-dispersible polyisocyanate mixtures, a process for their production and their use as initial component in the production of polyurethane plastics.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: August 17, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Josef Laas, Martin Brahm, Reinhard Halpaap
  • Patent number: 6776925
    Abstract: The present invention relates to a process for the production of polyether polyols by polyaddition of alkylene oxides onto starter compounds containing active hydrogen atoms conducted in the presence of a double-metal cyanide catalyst wherein a reaction mixture is guided at least once through a zone which has an energy density of at least 105 J/m3 and wherein the residence time of the reaction mixture in this zone is at least 10−6 seconds per pass.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: August 17, 2004
    Assignees: Bayer Aktiengesellschaft, Bayer Polymers LLC
    Inventors: Jörg Hofmann, Stephan Ehlers, Bernd Klinksiek, Lars Obendorf, Christian Steinlein, Bert Klesczewski, Jose F. Pazos
  • Publication number: 20040157875
    Abstract: The invention relates generally to naphthyridine derivatives of the formula 1
    Type: Application
    Filed: October 10, 2003
    Publication date: August 12, 2004
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Yamin Wang, William H. Bullock, Libing Chen
  • Publication number: 20040157904
    Abstract: The present invention relates to anilinopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
    Type: Application
    Filed: November 21, 2003
    Publication date: August 12, 2004
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Joachim Rudolph, Louis-David Cantin, Steven Magnuson, William Bullock, Ann-Marie Bullion, Libing Chen, Chih-Yuan Chuang, Sidney Liang, Dyuti Majumdar, Herbert Ogutu, Alan Olague, Ning Qi, Philip L. Wickens
  • Publication number: 20040158433
    Abstract: An analysis system for a process, having:
    Type: Application
    Filed: January 12, 2004
    Publication date: August 12, 2004
    Applicant: Bayer Aktiengesellschaft
    Inventors: Andrea Wimschneider, Martin Gerlach, Burkhard Frisch, Michael Lahme, Bernd Schmitz, Karsten Sommer
  • Publication number: 20040157278
    Abstract: The present invention relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1&agr; or TIMP1 nucleic acid or amino acid molecules in a clinical sample obtained from the patient, wherein Reg1&agr; or TIMP1 expression is indicative of the presence of colorectal cancer. The invention further relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1&agr; or TIMP1 nucleic acid or amino acid molecules in a clinical sample, in addition to detecting the presence of one or more additional colorectal cancer associated markers.
    Type: Application
    Filed: December 12, 2003
    Publication date: August 12, 2004
    Applicants: Bayer Corporation, Mayo Foundation for Medical Education & Research
    Inventors: Jon H. Astle, Christopher C. Burgess, Theodore J. Catino, Poornima Dwivedi, Maryanne Huntress, Karen Anne Johnson, Marcia E. Lewis, Peter J. Maimonis, Gary A. Molino, Susan H. Myerow, Arunthathi Thiagalingam, Lisa Allyn Boardman, Lawrence J. Burgart, Stephen N. Thibodeau, Sheryl Brown-Shimer
  • Publication number: 20040157263
    Abstract: Method for detecting at least one analyte, and device for performing the method comprising a measurement electrode having a biofunctional surface having recognition elements for the analyte, and one or more counterelectrodes. Analyte labeled with electrically active labeling units is brought into contact with the biofunctional surface. Either (a) a time-varying voltage or (b) a time-varying current is applied between a first counterelectrode and the measurement electrode. A measurement is made of either in case (a) the current or in case (b) the voltage between the first counterelectrode and the measurement electrode. Alternatively, a measurement is made of either in case (a) the current or in case (b) the voltage between a second or subsequent counterelectrode and the measurement electrode. This abstract is submitted with the understanding that it will not be used to interpret or limit the meaning or scope of the claims. 37 CFR § 1.72(b).
    Type: Application
    Filed: June 25, 2003
    Publication date: August 12, 2004
    Applicant: Bayer Aktiengesellschaft,
    Inventors: Edgar Diessel, Werner Hoheisel, Udo Merker, Jens Burmeister, Burkhard Kohler
  • Patent number: 6773756
    Abstract: The present invention is directed to a process for the manufacture of three-dimensional acoustically sound automotive insulation parts. In particular, the process includes mixing a two component polyurethane resin, applying the resin to a substrate, molding the substrate and then trimming and demolding the resin applied substrate.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: August 10, 2004
    Assignees: Bayer Polymers LLC, Bayer Aktiengesellschaft
    Inventors: Sven Meyer-Ahrens, Thomas J. Matwiczyk, Bin Lee, Michael A. Blaszkiewicz, Walter Guarnieri
  • Patent number: 6774207
    Abstract: The present invention relates to polyaspartate mixtures containing a) 5 to 70 equiv. %, based on the total equivalents of aspartate groups, of a cyclic polyaspartate corresponding to the formula wherein X1 represents the residue obtained by removing the amino groups from a cyclic polyamine having a functionality of n, R1 and R2 are identical or different and represent organic groups which are inert to isocyanate groups at a temperature of 100° C. or less, R3 and R4 are identical or different and represent hydrogen or organic groups which are inert towards isocyanate groups at a temperature of 100° C. or less and n is 2 to 4, and b) 30 to 95 equiv.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: August 10, 2004
    Assignees: Bayer Polymers LLC, Bayer Aktiengesellschaft
    Inventors: Karsten Danielmeier, Catherine M. Britsch, Rolf Gertzmann, Michele E. Vargo, Terrell Dean Wayt, Edward P. Squiller, Richard R. Roesler
  • Patent number: 6774239
    Abstract: This invention relates to the preparation of N,N′-carbonyldiazoles in a particularly advantageous manner by reacting corresponding azolide salts with phosgene in an aromatic compound or an ether as solvent. The azolide salts are preferably prepared by a novel process from an azole that is reacted with a compound of the formula M′R7 or MgR8Z′ in the presence of a solvent.
    Type: Grant
    Filed: August 15, 2002
    Date of Patent: August 10, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Johannes Scherer, Alexander Klausener, Robert Söllner
  • Patent number: 6774086
    Abstract: There are described derivatives of benzoylcyclohexanediones of the formula (I) and their use as herbicides. In this formula (I), R1a, R1b, R1c, R2, R3, R4 and R5 are various radicals, X1 is a bridging atom, X2 a carbon chain and X3 a chalcogen atom.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 10, 2004
    Assignee: Bayer CropScience GmbH
    Inventors: Thomas Seitz, Lothar Willms, Andreas van Almsick, Hermann Bieringer, Thomas Auler, Hubert Menne